Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

FDA has granted a Breakthrough Device Designation to Active Implants’ NUsurface® Meniscus Implant. Active Implants, LLC develops orthopedic implant solutions for joint preservation. The NUsurface Meniscus Implant is the first “artificial meniscus” to be marketed in Europe and, if cleared by the FDA, would be the first artificial meniscus in the United States.